Relmada Therapeutics, Inc.

NasdaqGS:RLMD Stock Report

Market Cap: US$84.5m

Relmada Therapeutics, Inc. Company Information

Relmada Therapeutics, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Relmada Therapeutics, Inc.
  • Ticker: RLMD
  • Exchange: NasdaqGS
  • Founded: NaN
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$84.488m
  • Shares Outstanding: 30.17m
  • Website: https://www.relmada.com

Number of Employees

Location

  • Relmada Therapeutics, Inc.
  • 2222 Ponce de Leon Boulevard
  • Floor 3
  • Coral Gables
  • Florida
  • 33134
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
RLMDNasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDMay 2014
4E2BST (Boerse-Stuttgart)YesCommon StockDEEURMay 2014

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/25 18:55
End of Day Share Price 2024/11/25 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.